title: Transforming growth factor-β3 regulates assembly of a non-fibrotic matrix in a 3D corneal model.
abstract: Corneal tissue engineering has attracted the attention of many researchers over the years, in part due to the cornea's avascularity and relatively straightforward structure. However, the highly organized and structured nature of this optically clear tissue has presented a great challenge. We have previously developed a model in which human corneal fibroblasts (HCFs) are stimulated by a stable vitamin C (VitC) derivative to self-assemble an extracellular matrix (ECM). Addition of TGFβ1 enhanced the assembly of ECM; however, it was accompanied by the upregulation of specific fibrotic markers. In this study, we tested the effects of all three TGFβ isoforms (-β1, -β2 and -β3) on ECM production, as well as expression of fibrotic markers. HCFs were grown in four media conditions for 4 weeks: control, VitC only; T1, VitC + TGFβ1; T2, VitC + TGFβ2; and T3, VitC + TGFβ3. The cultures were analysed with western blots, TEM and indirect immunofluorescence (IF). Compared to controls, all TGFβ isoforms stimulated matrix production by about three-fold. IF showed the presence of type III collagen and smooth muscle actin (SMA) in T1 and T2; however, T3 showed little to no expression. In western blots, T3 stimulated a lower type III:type I collagen ratio when compared to the other conditions. In addition, TEM indicated that T3 stimulated a higher level of matrix alignment and organization. HCFs stimulated by VitC and TGFβ3 appear to generate a matrix that mimics the normal adult or developing human cornea, whereas TGF-β1 and -β2 drive the constructs towards a more fibrotic path.
authors: Department of Ophthalmology, Harvard Medical School, Boston, MA, USA.
authors: D
authors: D
authors: Karamichos
authors: A E K
authors: AE
authors: Hutcheon
authors: J D
authors: JD
authors: Zieske
references: J Tissue Eng Regen Med. 2009 Aug;3(6):442-9
references: 19415764
references: Invest Ophthalmol Vis Sci. 2006 May;47(5):1886-94
references: 16638995
references: Exp Eye Res. 2008 Mar;86(3):506-11
references: 18237730
references: Science. 1987 Sep 11;237(4820):1333-6
references: 2442813
references: Ophthalmology. 1997 Mar;104(3):360-8
references: 9082257
references: J Biol Chem. 2005 Sep 23;280(38):32634-9
references: 16169858
references: Dev Dyn. 2008 Oct;237(10):2705-15
references: 18624285
references: Ann Plast Surg. 1994 Aug;33(2):148-51
references: 7979045
references: Exp Cell Res. 1994 Oct;214(2):621-33
references: 7523155
references: Invest Ophthalmol Vis Sci. 2010 Mar;51(3):1382-8
references: 19875671
references: Proc Natl Acad Sci U S A. 1987 Aug;84(16):5788-92
references: 2886992
references: In Vitro Cell Dev Biol Anim. 1999 Oct;35(9):515-26
references: 10548433
references: Science. 1999 Dec 10;286(5447):2169-72
references: 10591651
references: Development. 1990 Oct;110(2):609-20
references: 1723948
references: Invest Ophthalmol Vis Sci. 2006 Aug;47(8):3311-7
references: 16877396
references: J Biol Chem. 2000 May 5;275(18):13918-23
references: 10788517
references: Proc Natl Acad Sci U S A. 2003 Dec 23;100(26):15346-51
references: 14660789
references: J Cell Biol. 1983 Sep;97(3):849-57
references: 6885921
references: Exp Eye Res. 2002 Dec;75(6):645-57
references: 12470966
references: Expert Opin Biol Ther. 2008 Oct;8(10):1485-93
references: 18774917
references: Clin Transl Sci. 2009 Apr;2(2):162-4
references: 20443883
references: Tissue Eng. 2003 Aug;9(4):679-88
references: 13678446
references: Biomed Mater. 2007 Sep;2(3):S121-5
references: 18458455
references: N Engl J Med. 1994 Nov 10;331(19):1286-92
references: 7935686
references: Exp Eye Res. 2009 Aug;89(2):218-23
references: 19328782
references: Clin Exp Ophthalmol. 2010 Mar;38(2):211-24
references: 20398109
references: Development. 1990 Oct;110(2):445-60
references: 2133548
references: Invest Ophthalmol Vis Sci. 1999 Aug;40(9):1952-8
references: 10440248
references: Acta Ophthalmol (Copenh). 1991 Oct;69(5):635-40
references: 1776418
references: J Cell Physiol. 1999 Jun;179(3):325-35
references: 10228951
references: Development. 1991 Jan;111(1):131-43
references: 1707784
references: Graefes Arch Clin Exp Ophthalmol. 2006 Apr;244(4):502-6
references: 16133028
references: Graefes Arch Clin Exp Ophthalmol. 2009 Apr;247(4):535-9
references: 18941767
references: Cornea. 2006 Oct;25(9):1034-42
references: 17133049
references: Prog Retin Eye Res. 2003 Mar;22(2):113-33
references: 12604055
references: Int J Pharm. 2003 Jan 2;250(1):191-201
references: 12480285
references: J Biomater Sci Polym Ed. 2008;19(8):1047-63
references: 18644230
references: Science. 1983 Mar 18;219(4590):1329-31
references: 6572416
references: Mol Reprod Dev. 1992 Jun;32(2):91-8
references: 1637557
references: Development. 1991 Jan;111(1):117-30
references: 2015789
references: Prog Retin Eye Res. 1999 May;18(3):311-56
references: 10192516
references: Cornea. 2007 Dec;26(10):1258-60
references: 18043186
references: Exp Eye Res. 2001 Jan;72(1):33-9
references: 11133180
references: J Biomed Mater Res A. 2010 Nov;95(2):447-53
references: 20648540
references: Invest Ophthalmol Vis Sci. 2008 Dec;49(12):5325-31
references: 18708614
references: Wound Repair Regen. 2006 Sep-Oct;14(5):516-25
references: 17014662
references: Invest Ophthalmol Vis Sci. 1992 Nov;33(12):3283-91
references: 1428703
references: Int J Biochem Cell Biol. 1997 Jan;29(1):63-78
references: 9076942
references: Invest Ophthalmol Vis Sci. 1993 Jun;34(7):2316-24
references: 7685009
references: Exp Eye Res. 2003 Nov;77(5):581-92
references: 14550400
references: J Tissue Eng Regen Med. 2010 Oct;4(7):497-504
references: 20205160
references: Invest Ophthalmol Vis Sci. 2007 Sep;48(9):4050-60
references: 17724187
references: Mol Vis. 2010 Oct 29;16:2192-201
references: 21139684
references: J Cell Sci. 1995 Mar;108 ( Pt 3):985-1002
references: 7542672
references: J Cell Biol. 1991 Nov;115(4):1091-105
references: 1955457
references: Invest Ophthalmol Vis Sci. 1998 Feb;39(2):276-83
references: 9477983